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Introduction: Kleine–Levin syndrome (KLS) is a rare syndrome of periodic hypersomnia and
behavioral and cognitive symptoms based on clinical criteria. In the setting of differential
diagnosis of hypersomnia disorders, an objective diagnostic aid is desirable. A promis-
ing modality is single photon emission computed tomography (SPECT). As intraepisodal
investigations are difficult to perform, an interepisodal investigation would be very helpful.
Another aim of the study was to correlate SPECT findings to prognosis.
Methods and Materials: Twenty-four KLS-patients were categorized as severe or non-
severe based on clinical characteristics.The clinical characteristics were analyzed in relation
to SPECT-examinations performed between hypersomnia periods (interepisodal) or after
remission, as a clinical routine investigation.
Results: Forty-eight percent of the KLS-patients have hypoperfusion in the temporal
or fronto-temporal regions. In patients that have undergone remission, 56% show that
pattern. There were no specific findings related to prognosis.
Discussion/Conclusion: SPECT might be a diagnostic aid, in a setting of hypersomnia
experience. With a sensitivity of 48%, interepisodal SPECT alone cannot be used for
diagnosing KLS.
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INTRODUCTION
The Kleine–Levin syndrome (KLS) is a rare disorder of periodic
hypersomnia and associated symptoms. The diagnosis is based
on clinical criteria according to the American Academy of Sleep
Medicine Classification (2005), including the cardinal symptom of
periodic hypersomnia and behavioral and cognitive disturbances
(1). The rarity of the syndrome, in combination with the clini-
cal difficulties in differentiating from other hypersomnias (such
as narcolepsy, delayed sleep phase syndrome, psychiatric disorder,
fatigue from infections or MS, and narcotic drug abuse) makes an
objective diagnostic aid highly desirable.
In search for an objective diagnostic aid there has been promis-
ing indications of a common HLA-subtype (2), but a larger mate-
rial could not verify the finding (3). Decreased levels of orexin
in the cerebrospinal fluid have been observed in a case dur-
ing hypersomnia (4). Another case showed normal intraepisodal
orexin (5).
Radiological examinations have not been able to show any
specific pathology regarding brain structural changes. On the
other hand, cerebral perfusion examined by single photon emis-
sion computed tomography (SPECT) has shown abnormal per-
fusion patterns in several case reports and case series (6–8).
Discussions have been focused on SPECT as a possible tool of
explaining the pathophysiology of KLS. Hypotheses regarding
KLS pathophysiology include disturbances in the hypothalamic–
pituitary axis, the diencephalon, and thalamo-cortical circuits
(9–12).
Intraepisodal SPECT has showed a predominance of
hypoperfusion in the thalami and basal ganglia (13). The finding
has been consistent and a recent publication stated that intraepiso-
dal SPECT could be used as a diagnostic aid in KLS (13, 14). In
clinical praxis, however, SPECT-examinations may be difficult to
perform, by several reasons. Firstly, the patient has to be admitted
to a department with access to nuclear medicine facilities during an
ongoing episode. Secondly, there might be problems with patient
cooperation during ongoing hypersomnia. Thus, it would be of
great interest to find consistent and specific abnormal perfusion
patterns interepisodically.
Our group published early reports on abnormal perfusion pat-
terns 2 weeks after an episode and also 7 years after remission.
The patient showed bilateral, although predominately left-sided,
fronto-temporal, and right parietal hypoperfusion. And additive
finding in this patient was a persistent short-term memory dys-
function, the latter indicating persisting damage,and maybe a non-
benign course of the disease (7). In a case series of four patients,
two patients showed temporal and fronto-temporal hypoperfu-
sion in between episodes or in remission (13). Other groups have
shown diverse findings: in one case of posthypersomnic manic and
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psychotic symptoms, SPECT showed decreased perfusion in the
basal ganglia, hypothalamus, and right fronto-temporal regions
(15). Another case showed mesial temporal hypoperfusion both
during and between hypersomnia periods (16).
In our Scandinavian group, we have consequently been per-
forming SPECT-examinations in asymptomatic periods or after
remission in order to investigate the frequency of temporal/frontal
hypoperfusion and evaluate the diagnostic potential of this find-
ing. Thus, the aim of this study is to elucidate whether measure-
ments of brain perfusion is a practicable aid in diagnosing KLS
between hypersomnia episodes and if specific findings are associ-
ated with severity of the disorder, i.e., we aimed to investigate if
SPECT also could be a prognostic aid.
MATERIALS AND METHODS
We consecutively included 25 patients (11 men and 14 women)
diagnosed with KLS, according to the American Academy of Sleep
Medicine (2005) who had undergone SPECT as a part if the clini-
cal investigation protocol. Patients were grouped into “non-severe
KLS” and “severe KLS” based on their relation to median val-
ues (according to Arnulf et al.) of disease duration (m= 8 years),
frequency of periods (m= every 3.5 months), and duration of
periods (m= 10 days) (1). If any of these parameters exceeded
the median value the patient was classified as “severe KLS.” All
patients were examined in periods between hypersomnia (n= 12)
or after remission (n= 9). Remission was defined as having no
hypersomnia periods during the 1.5 years preceding the SPECT
examination.
Single photon emission computed tomography investigations
were performed using a General Electric XRT single head detec-
tor gamma camera 650 MBq 99m-Tc-HMPAO (CERETEC®)
was administered intravenously and each patient was scanned
for 32 min (64 projections in a 128× 128 matrix acquisi-
tion). Tomographic slices were reconstructed in the transax-
ial, coronal, and sagittal planes using a filtered back-projection
method, a Hanning prefilter with 0.8 cycles/cm cut-off fre-
quency, and a Ramp filter without attenuation correction. The
images were interpreted by an experienced specialist in nuclear
medicine and compared to the standard interpretation of the
method (17).
A control group was not ethically possible, due to the radioac-
tive isotope used in the investigation.
Informed consent was obtained from all participants.
RESULTS
The present study shows that 48% of the investigated patients with
KLS have abnormal perfusion between hypersomnia periods, as
detected by SPECT. As shown in Table 1, 7 out of 16 patients
with an active disease showed hypoperfusion in temporal and/or
frontal regions. Patients in remission had temporal and/or frontal
hypoperfusion in five out of nine cases. In total, 12 out of 25
patients showed hypoperfusion in temporal and/or frontal regions
of the brain. All pathological findings in these patients were seen
bilaterally or on the right side.
In patients categorized as severe, 5 out of 13 patients showed
temporal and/or frontal hypoperfusion. In the non-severe patients,
7 out of 12 showed hypoperfusion in the temporal and/or frontal
regions. No further regions of abnormal perfusion could be
detected in any patient.
Figures 1 and 2 show two KLS-patients with active disease, who
have normal perfusion (Figure 1) and temporal hypoperfusion
(Figure 2) on SPECT-examinations.
DISCUSSION
This study focuses on frontal/temporal hypoperfusion between
episodes or after remission, in relation to results from other
groups focusing on thalamic/diencephalic hypoperfusion during
episodes. With 48% of patients showing non-episodal (interepiso-
dal or post-remission) hypoperfusion in temporal or fronto-
temporal regions it is clearly of interest to investigate this finding
in more depth and possibly relate to different characteristics of the
individual patients (3, 12, 15, 18). A sensitivity of 48%, however,
is not considered strong enough to use interepisodal SPECT as an
isolated tool in the diagnostic process. A combination of SPECT
and specific symptomatology could possibly lead to a combined
higher sensitivity than with SPECT alone. The sensitivity is to be
compared to intraepisodal findings where hypoperfusion in the
thalami and the basal ganglia is a consistent finding (13). For an
experienced sleep neurologist, however, SPECT might be a help-
ful complement to the clinical diagnostic process, for instance if
symptoms are suspected to be functional whereas a pathological
perfusion pattern may support an organic explanation.
Another finding is that in patients that have undergone remis-
sion, 56% showed persisting hypoperfusion, supporting a chronic
damage, not yet correlated to clinical follow up. As temporal and
fronto-temporal regions are involved in working memory per-
formance, the findings are consistent with our earlier findings of
Table 1 | SPECT findings.
Temporal
hypoperfusion
Fronto-temporal
hypoperfusion
Frontal
hypoperfusion
Normal
perfusion
Bilateral
hypoperfusion
Left
hypoperfusion
Right
hypoperfusion
Men Women
Active
non-severe
1 1 3 2 2 3
Active severe 4 1 6 1 2 2 4 7
Remission
non-severe
2 2 1 2 4 1 3 4
Remission
severe
2 2
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FIGURE 1 | A female patient with active Kleine–Levin syndrome with a
normal SPECT perfusion pattern.
persisting cognitive deficits in the working memory domain (8, 13,
15, 19). The latter could be indicative of a course of the disorder
that is not benign.
In this study, no obvious conclusions can be drawn regard-
ing the prognostic value of SPECT, although more patients in
remission have areas of hypoperfusion than the group in total.
Additional studies of the cognitive function of these patients
will be analyzed in the future to further elucidate the correla-
tion to prognosis. A recent review of the literature found that
only small series of brain perfusion imaging has been published,
but in these studies, there are indications of persistent tempo-
ral and/or frontal hypoperfusion even after remission (3, 13, 15).
Being the largest published material on interepisodal SPECT, the
present study supports previously published results of fronto-
temporal hypoperfusion persisting beyond the active phases of
the disease. Patients in remission with abnormal perfusion showed
predominantly right-sided or bilateral hypoperfusion.
The present study has some obvious limitations. The hetero-
geneous group of patients, regarding active/remission, sympto-
matology, and disease duration, might clearly be confounding as
perfusion patterns theoretically could be changing over time and
be associated to specific symptom patterns. SPECT findings were
not analyzed in relation to specific clinical symptoms or findings
in neuropsychological tests, something that might be of interest
in future investigations. The absence of a matched control group,
obviously, is a major limitation, though a limitation shared with
FIGURE 2 | A male patient with active Kleine–Levin Syndrome with
medial temporal unilateral hypoperfusion (arrow).
other studies in the field due to the radioactive isotope used in
SPECT (14).
CONCLUSION
This study confirms results in previously published case reports
and we suggest that SPECT could be an additive diagnostic tool in
KLS. Regarding the low sensitivity of 48%, interepisodal SPECT
must be used in a setting of vast clinical experience of the diag-
nostic criteria and clinical variety of the disorder. Sensitivity of
SPECT seems lower interepisodically than intraepisodically.
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